209. Billiga aktier inom biotech

from Börslunch · host EFN Ekonomikanalen

Bioteknik är en sektor som ligger rätt i tiden då efterfrågan på läkemedel förväntas öka när världens befolkning blir allt äldre. Ulrica Slåne Bjerke, förvaltare på Arctic Asset Management, berättar i EFN Marknad om hur du ska tänka om du vill investera i sektorn.

Episode metadata supplied by the publisher feed · Published May 6, 2022

Embed this episode

Attribution link and audio player

Ready to play

209. Billiga aktier inom biotech

0:00 18:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Börslunch?

This episode is 18 minutes long.

When was this Börslunch episode published?

This episode was published on May 6, 2022.

Can I download this Börslunch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!